Detalhe da pesquisa
1.
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Lancet
; 398(10313): 1811-1824, 2021 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34672967
2.
Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo-controlled trial in patients with type 2 diabetes using metformin.
Diabetes Obes Metab
; 21(9): 2048-2057, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31050143